Structural and genetic basis for development of broadly neutralizing influenza antibodies
The events leading to the generation of broadly neutralizing antibodies to influenza viruses, which may hold the key to developing a universal flu vaccine, are elucidated. Vaccine-friendly anti-influenza antibodies The study of broadly neutralizing antibodies to influenza virus may pave the way for...
Gespeichert in:
Veröffentlicht in: | Nature 2012-09, Vol.489 (7417), p.566-570 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 570 |
---|---|
container_issue | 7417 |
container_start_page | 566 |
container_title | Nature |
container_volume | 489 |
creator | Lingwood, Daniel McTamney, Patrick M. Yassine, Hadi M. Whittle, James R. R. Guo, Xiaoti Boyington, Jeffrey C. Wei, Chih-Jen Nabel, Gary J. |
description | The events leading to the generation of broadly neutralizing antibodies to influenza viruses, which may hold the key to developing a universal flu vaccine, are elucidated.
Vaccine-friendly anti-influenza antibodies
The study of broadly neutralizing antibodies to influenza virus may pave the way for the generation of a universal vaccine. Here, Daniel Lingwood
et al
. define the minimal requirements for high-affinity binding of such broadly neutralizing antibodies. They show that binding does not involve light chains, and that most of the crucial heavy-chain contacts are germline encoded. Membrane-bound antibodies are shown to function despite their initially very low affinity.
Influenza viruses take a yearly toll on human life despite efforts to contain them with seasonal vaccines. These viruses evade human immunity through the evolution of variants that resist neutralization. The identification of antibodies that recognize invariant structures on the influenza haemagglutinin (HA) protein have invigorated efforts to develop universal influenza vaccines. Specifically, antibodies to the highly conserved stem region of HA neutralize diverse viral subtypes. These antibodies largely derive from a specific antibody gene, heavy-chain variable region
IGHV1-69
, after limited affinity maturation from their germline ancestors
1
,
2
, but how HA stimulates naive B cells to mature and induce protective immunity is unknown. To address this question, we analysed the structural and genetic basis for their engagement and maturation into broadly neutralizing antibodies. Here we show that the germline-encoded precursors of these antibodies act as functional B-cell antigen receptors (BCRs) that initiate subsequent affinity maturation. Neither the germline precursor of a prototypic antibody, CR6261 (ref.
3
), nor those of two other natural human IGHV1-69 antibodies, bound HA as soluble immunoglobulin-G (IgG). However, all three IGHV1-69 precursors engaged HA when the antibody was expressed as cell surface IgM. HA triggered BCR-associated tyrosine kinase signalling by germline transmembrane IgM. Recognition and virus neutralization was dependent solely on the heavy chain, and affinity maturation of CR6261 required only seven amino acids in the complementarity-determining region (CDR) H1 and framework region 3 (FR3) to restore full activity. These findings provide insight into the initial events that lead to the generation of broadly neutralizing antibodies to influenza, informi |
doi_str_mv | 10.1038/nature11371 |
format | Article |
fullrecord | <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7095019</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A660273178</galeid><sourcerecordid>A660273178</sourcerecordid><originalsourceid>FETCH-LOGICAL-c771t-2bead73166bf987eff94064558a5b10ffafc362b616fb917ac3a7f0478ac377c3</originalsourceid><addsrcrecordid>eNp10u9r1DAYB_Aiijunr3wvZUNQtDNp2iR9IxyHPwZDwU3EVyFNn3QZveSWpMPtrze3O7c7PemLluSTb57mSZY9x-gII8LfWRlHDxgThh9kE1wxWlSUs4fZBKGSF4gTupc9CeECIVRjVj3O9sqyIWVJ2ST7eRr9qFKAHHJpu7wHC9GovJXBhFw7n3dwBYNbzMHG3Om89U52w3VuYYxpkbkxts-N1cMI9kamjGha1xkIT7NHWg4Bnq3f-9n3jx_OZp-Lk6-fjmfTk0IxhmNRtiA7RjClrW44A62bCtGqrrmsW4y0lloRWrYUU902mElFJNOoYjx9MabIfvZ-lbsY2zl0KtWZ6hILb-bSXwsnjdieseZc9O5KMNTUCDcp4GAV4EI0IigTQZ0rZy2oKDCqSclRQq_Wu3h3OUKIYm6CgmGQFtwYkuO4IjVHLNHDv-iFG71NZ5BUU2NccsbvVS8HEOkAXSpOLUPFlFJUpiO5VcUOtWxS-hNnQZs0vOUPdni1MJdiEx3tQOnpYG7UztTXWwuSifAr9nIMQRyfftu2b_5vp2c_Zl92auVdCB70Xd8wEsvbLTZud9IvNlt9Z_9c5wReroEMSg7aS6tMuHeUNDW9DXq7ciFN2R78Zov-3fc3RMAOxA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1095112878</pqid></control><display><type>article</type><title>Structural and genetic basis for development of broadly neutralizing influenza antibodies</title><source>MEDLINE</source><source>Springer Nature - Complete Springer Journals</source><source>Nature Journals Online</source><creator>Lingwood, Daniel ; McTamney, Patrick M. ; Yassine, Hadi M. ; Whittle, James R. R. ; Guo, Xiaoti ; Boyington, Jeffrey C. ; Wei, Chih-Jen ; Nabel, Gary J.</creator><creatorcontrib>Lingwood, Daniel ; McTamney, Patrick M. ; Yassine, Hadi M. ; Whittle, James R. R. ; Guo, Xiaoti ; Boyington, Jeffrey C. ; Wei, Chih-Jen ; Nabel, Gary J. ; Argonne National Lab. (ANL), Argonne, IL (United States). Advanced Photon Source (APS)</creatorcontrib><description>The events leading to the generation of broadly neutralizing antibodies to influenza viruses, which may hold the key to developing a universal flu vaccine, are elucidated.
Vaccine-friendly anti-influenza antibodies
The study of broadly neutralizing antibodies to influenza virus may pave the way for the generation of a universal vaccine. Here, Daniel Lingwood
et al
. define the minimal requirements for high-affinity binding of such broadly neutralizing antibodies. They show that binding does not involve light chains, and that most of the crucial heavy-chain contacts are germline encoded. Membrane-bound antibodies are shown to function despite their initially very low affinity.
Influenza viruses take a yearly toll on human life despite efforts to contain them with seasonal vaccines. These viruses evade human immunity through the evolution of variants that resist neutralization. The identification of antibodies that recognize invariant structures on the influenza haemagglutinin (HA) protein have invigorated efforts to develop universal influenza vaccines. Specifically, antibodies to the highly conserved stem region of HA neutralize diverse viral subtypes. These antibodies largely derive from a specific antibody gene, heavy-chain variable region
IGHV1-69
, after limited affinity maturation from their germline ancestors
1
,
2
, but how HA stimulates naive B cells to mature and induce protective immunity is unknown. To address this question, we analysed the structural and genetic basis for their engagement and maturation into broadly neutralizing antibodies. Here we show that the germline-encoded precursors of these antibodies act as functional B-cell antigen receptors (BCRs) that initiate subsequent affinity maturation. Neither the germline precursor of a prototypic antibody, CR6261 (ref.
3
), nor those of two other natural human IGHV1-69 antibodies, bound HA as soluble immunoglobulin-G (IgG). However, all three IGHV1-69 precursors engaged HA when the antibody was expressed as cell surface IgM. HA triggered BCR-associated tyrosine kinase signalling by germline transmembrane IgM. Recognition and virus neutralization was dependent solely on the heavy chain, and affinity maturation of CR6261 required only seven amino acids in the complementarity-determining region (CDR) H1 and framework region 3 (FR3) to restore full activity. These findings provide insight into the initial events that lead to the generation of broadly neutralizing antibodies to influenza, informing the rational design of vaccines to elicit such antibodies and providing a model relevant to other infectious diseases, including human immunodeficiency virus/AIDS. The data further suggest that selected immunoglobulin genes recognize specific protein structural ‘patterns’ that provide a substrate for further affinity maturation.</description><identifier>ISSN: 0028-0836</identifier><identifier>EISSN: 1476-4687</identifier><identifier>DOI: 10.1038/nature11371</identifier><identifier>PMID: 22932267</identifier><identifier>CODEN: NATUAS</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>631/208/248 ; 631/250/2152/2153/1291 ; 631/326/596/1578 ; Amino Acid Sequence ; Amino acids ; Antibodies ; Antibodies, Neutralizing - chemistry ; Antibodies, Neutralizing - genetics ; Antibodies, Neutralizing - immunology ; Antibodies, Viral - chemistry ; Antibodies, Viral - genetics ; Antibodies, Viral - immunology ; Antibody Affinity - immunology ; Binding Sites, Antibody - immunology ; Biological and medical sciences ; Complementarity Determining Regions - chemistry ; Complementarity Determining Regions - immunology ; Cross Reactions - immunology ; Fundamental and applied biological sciences. Psychology ; Genetic aspects ; Health aspects ; Humanities and Social Sciences ; Humans ; Immunoglobulin G - chemistry ; Immunoglobulin G - immunology ; Immunoglobulin Heavy Chains - chemistry ; Immunoglobulin Heavy Chains - immunology ; Immunoglobulin M - chemistry ; Immunoglobulin M - immunology ; Infectious diseases ; Influenza ; Influenza vaccines ; Influenza Vaccines - immunology ; letter ; Light ; Microbiology ; Models, Molecular ; Molecular Sequence Data ; multidisciplinary ; Mutation ; Neutralization ; Orthomyxoviridae - chemistry ; Orthomyxoviridae - classification ; Orthomyxoviridae - immunology ; Prevention ; Protein Conformation ; Proteins ; Receptors, Antigen, B-Cell - chemistry ; Receptors, Antigen, B-Cell - immunology ; Science ; Science (multidisciplinary) ; Sequence Alignment ; Testing ; Vaccines ; Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies ; Viral antibodies ; Virology</subject><ispartof>Nature, 2012-09, Vol.489 (7417), p.566-570</ispartof><rights>Springer Nature Limited 2012</rights><rights>2014 INIST-CNRS</rights><rights>COPYRIGHT 2012 Nature Publishing Group</rights><rights>Copyright Nature Publishing Group Sep 27, 2012</rights><rights>Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved. 2012</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c771t-2bead73166bf987eff94064558a5b10ffafc362b616fb917ac3a7f0478ac377c3</citedby><cites>FETCH-LOGICAL-c771t-2bead73166bf987eff94064558a5b10ffafc362b616fb917ac3a7f0478ac377c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1038/nature11371$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1038/nature11371$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>230,314,777,781,882,27905,27906,41469,42538,51300</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=26395671$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22932267$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://www.osti.gov/biblio/1053280$$D View this record in Osti.gov$$Hfree_for_read</backlink></links><search><creatorcontrib>Lingwood, Daniel</creatorcontrib><creatorcontrib>McTamney, Patrick M.</creatorcontrib><creatorcontrib>Yassine, Hadi M.</creatorcontrib><creatorcontrib>Whittle, James R. R.</creatorcontrib><creatorcontrib>Guo, Xiaoti</creatorcontrib><creatorcontrib>Boyington, Jeffrey C.</creatorcontrib><creatorcontrib>Wei, Chih-Jen</creatorcontrib><creatorcontrib>Nabel, Gary J.</creatorcontrib><creatorcontrib>Argonne National Lab. (ANL), Argonne, IL (United States). Advanced Photon Source (APS)</creatorcontrib><title>Structural and genetic basis for development of broadly neutralizing influenza antibodies</title><title>Nature</title><addtitle>Nature</addtitle><addtitle>Nature</addtitle><description>The events leading to the generation of broadly neutralizing antibodies to influenza viruses, which may hold the key to developing a universal flu vaccine, are elucidated.
Vaccine-friendly anti-influenza antibodies
The study of broadly neutralizing antibodies to influenza virus may pave the way for the generation of a universal vaccine. Here, Daniel Lingwood
et al
. define the minimal requirements for high-affinity binding of such broadly neutralizing antibodies. They show that binding does not involve light chains, and that most of the crucial heavy-chain contacts are germline encoded. Membrane-bound antibodies are shown to function despite their initially very low affinity.
Influenza viruses take a yearly toll on human life despite efforts to contain them with seasonal vaccines. These viruses evade human immunity through the evolution of variants that resist neutralization. The identification of antibodies that recognize invariant structures on the influenza haemagglutinin (HA) protein have invigorated efforts to develop universal influenza vaccines. Specifically, antibodies to the highly conserved stem region of HA neutralize diverse viral subtypes. These antibodies largely derive from a specific antibody gene, heavy-chain variable region
IGHV1-69
, after limited affinity maturation from their germline ancestors
1
,
2
, but how HA stimulates naive B cells to mature and induce protective immunity is unknown. To address this question, we analysed the structural and genetic basis for their engagement and maturation into broadly neutralizing antibodies. Here we show that the germline-encoded precursors of these antibodies act as functional B-cell antigen receptors (BCRs) that initiate subsequent affinity maturation. Neither the germline precursor of a prototypic antibody, CR6261 (ref.
3
), nor those of two other natural human IGHV1-69 antibodies, bound HA as soluble immunoglobulin-G (IgG). However, all three IGHV1-69 precursors engaged HA when the antibody was expressed as cell surface IgM. HA triggered BCR-associated tyrosine kinase signalling by germline transmembrane IgM. Recognition and virus neutralization was dependent solely on the heavy chain, and affinity maturation of CR6261 required only seven amino acids in the complementarity-determining region (CDR) H1 and framework region 3 (FR3) to restore full activity. These findings provide insight into the initial events that lead to the generation of broadly neutralizing antibodies to influenza, informing the rational design of vaccines to elicit such antibodies and providing a model relevant to other infectious diseases, including human immunodeficiency virus/AIDS. The data further suggest that selected immunoglobulin genes recognize specific protein structural ‘patterns’ that provide a substrate for further affinity maturation.</description><subject>631/208/248</subject><subject>631/250/2152/2153/1291</subject><subject>631/326/596/1578</subject><subject>Amino Acid Sequence</subject><subject>Amino acids</subject><subject>Antibodies</subject><subject>Antibodies, Neutralizing - chemistry</subject><subject>Antibodies, Neutralizing - genetics</subject><subject>Antibodies, Neutralizing - immunology</subject><subject>Antibodies, Viral - chemistry</subject><subject>Antibodies, Viral - genetics</subject><subject>Antibodies, Viral - immunology</subject><subject>Antibody Affinity - immunology</subject><subject>Binding Sites, Antibody - immunology</subject><subject>Biological and medical sciences</subject><subject>Complementarity Determining Regions - chemistry</subject><subject>Complementarity Determining Regions - immunology</subject><subject>Cross Reactions - immunology</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Genetic aspects</subject><subject>Health aspects</subject><subject>Humanities and Social Sciences</subject><subject>Humans</subject><subject>Immunoglobulin G - chemistry</subject><subject>Immunoglobulin G - immunology</subject><subject>Immunoglobulin Heavy Chains - chemistry</subject><subject>Immunoglobulin Heavy Chains - immunology</subject><subject>Immunoglobulin M - chemistry</subject><subject>Immunoglobulin M - immunology</subject><subject>Infectious diseases</subject><subject>Influenza</subject><subject>Influenza vaccines</subject><subject>Influenza Vaccines - immunology</subject><subject>letter</subject><subject>Light</subject><subject>Microbiology</subject><subject>Models, Molecular</subject><subject>Molecular Sequence Data</subject><subject>multidisciplinary</subject><subject>Mutation</subject><subject>Neutralization</subject><subject>Orthomyxoviridae - chemistry</subject><subject>Orthomyxoviridae - classification</subject><subject>Orthomyxoviridae - immunology</subject><subject>Prevention</subject><subject>Protein Conformation</subject><subject>Proteins</subject><subject>Receptors, Antigen, B-Cell - chemistry</subject><subject>Receptors, Antigen, B-Cell - immunology</subject><subject>Science</subject><subject>Science (multidisciplinary)</subject><subject>Sequence Alignment</subject><subject>Testing</subject><subject>Vaccines</subject><subject>Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies</subject><subject>Viral antibodies</subject><subject>Virology</subject><issn>0028-0836</issn><issn>1476-4687</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNp10u9r1DAYB_Aiijunr3wvZUNQtDNp2iR9IxyHPwZDwU3EVyFNn3QZveSWpMPtrze3O7c7PemLluSTb57mSZY9x-gII8LfWRlHDxgThh9kE1wxWlSUs4fZBKGSF4gTupc9CeECIVRjVj3O9sqyIWVJ2ST7eRr9qFKAHHJpu7wHC9GovJXBhFw7n3dwBYNbzMHG3Om89U52w3VuYYxpkbkxts-N1cMI9kamjGha1xkIT7NHWg4Bnq3f-9n3jx_OZp-Lk6-fjmfTk0IxhmNRtiA7RjClrW44A62bCtGqrrmsW4y0lloRWrYUU902mElFJNOoYjx9MabIfvZ-lbsY2zl0KtWZ6hILb-bSXwsnjdieseZc9O5KMNTUCDcp4GAV4EI0IigTQZ0rZy2oKDCqSclRQq_Wu3h3OUKIYm6CgmGQFtwYkuO4IjVHLNHDv-iFG71NZ5BUU2NccsbvVS8HEOkAXSpOLUPFlFJUpiO5VcUOtWxS-hNnQZs0vOUPdni1MJdiEx3tQOnpYG7UztTXWwuSifAr9nIMQRyfftu2b_5vp2c_Zl92auVdCB70Xd8wEsvbLTZud9IvNlt9Z_9c5wReroEMSg7aS6tMuHeUNDW9DXq7ciFN2R78Zov-3fc3RMAOxA</recordid><startdate>20120927</startdate><enddate>20120927</enddate><creator>Lingwood, Daniel</creator><creator>McTamney, Patrick M.</creator><creator>Yassine, Hadi M.</creator><creator>Whittle, James R. R.</creator><creator>Guo, Xiaoti</creator><creator>Boyington, Jeffrey C.</creator><creator>Wei, Chih-Jen</creator><creator>Nabel, Gary J.</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>ATWCN</scope><scope>3V.</scope><scope>7QG</scope><scope>7QL</scope><scope>7QP</scope><scope>7QR</scope><scope>7RV</scope><scope>7SN</scope><scope>7SS</scope><scope>7ST</scope><scope>7T5</scope><scope>7TG</scope><scope>7TK</scope><scope>7TM</scope><scope>7TO</scope><scope>7U9</scope><scope>7X2</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>88G</scope><scope>88I</scope><scope>8AF</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BEC</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>BKSAR</scope><scope>C1K</scope><scope>CCPQU</scope><scope>D1I</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB.</scope><scope>KB0</scope><scope>KL.</scope><scope>L6V</scope><scope>LK8</scope><scope>M0K</scope><scope>M0S</scope><scope>M1P</scope><scope>M2M</scope><scope>M2O</scope><scope>M2P</scope><scope>M7N</scope><scope>M7P</scope><scope>M7S</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PATMY</scope><scope>PCBAR</scope><scope>PDBOC</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PSYQQ</scope><scope>PTHSS</scope><scope>PYCSY</scope><scope>Q9U</scope><scope>R05</scope><scope>RC3</scope><scope>S0X</scope><scope>SOI</scope><scope>7X8</scope><scope>OTOTI</scope><scope>5PM</scope></search><sort><creationdate>20120927</creationdate><title>Structural and genetic basis for development of broadly neutralizing influenza antibodies</title><author>Lingwood, Daniel ; McTamney, Patrick M. ; Yassine, Hadi M. ; Whittle, James R. R. ; Guo, Xiaoti ; Boyington, Jeffrey C. ; Wei, Chih-Jen ; Nabel, Gary J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c771t-2bead73166bf987eff94064558a5b10ffafc362b616fb917ac3a7f0478ac377c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>631/208/248</topic><topic>631/250/2152/2153/1291</topic><topic>631/326/596/1578</topic><topic>Amino Acid Sequence</topic><topic>Amino acids</topic><topic>Antibodies</topic><topic>Antibodies, Neutralizing - chemistry</topic><topic>Antibodies, Neutralizing - genetics</topic><topic>Antibodies, Neutralizing - immunology</topic><topic>Antibodies, Viral - chemistry</topic><topic>Antibodies, Viral - genetics</topic><topic>Antibodies, Viral - immunology</topic><topic>Antibody Affinity - immunology</topic><topic>Binding Sites, Antibody - immunology</topic><topic>Biological and medical sciences</topic><topic>Complementarity Determining Regions - chemistry</topic><topic>Complementarity Determining Regions - immunology</topic><topic>Cross Reactions - immunology</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Genetic aspects</topic><topic>Health aspects</topic><topic>Humanities and Social Sciences</topic><topic>Humans</topic><topic>Immunoglobulin G - chemistry</topic><topic>Immunoglobulin G - immunology</topic><topic>Immunoglobulin Heavy Chains - chemistry</topic><topic>Immunoglobulin Heavy Chains - immunology</topic><topic>Immunoglobulin M - chemistry</topic><topic>Immunoglobulin M - immunology</topic><topic>Infectious diseases</topic><topic>Influenza</topic><topic>Influenza vaccines</topic><topic>Influenza Vaccines - immunology</topic><topic>letter</topic><topic>Light</topic><topic>Microbiology</topic><topic>Models, Molecular</topic><topic>Molecular Sequence Data</topic><topic>multidisciplinary</topic><topic>Mutation</topic><topic>Neutralization</topic><topic>Orthomyxoviridae - chemistry</topic><topic>Orthomyxoviridae - classification</topic><topic>Orthomyxoviridae - immunology</topic><topic>Prevention</topic><topic>Protein Conformation</topic><topic>Proteins</topic><topic>Receptors, Antigen, B-Cell - chemistry</topic><topic>Receptors, Antigen, B-Cell - immunology</topic><topic>Science</topic><topic>Science (multidisciplinary)</topic><topic>Sequence Alignment</topic><topic>Testing</topic><topic>Vaccines</topic><topic>Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies</topic><topic>Viral antibodies</topic><topic>Virology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lingwood, Daniel</creatorcontrib><creatorcontrib>McTamney, Patrick M.</creatorcontrib><creatorcontrib>Yassine, Hadi M.</creatorcontrib><creatorcontrib>Whittle, James R. R.</creatorcontrib><creatorcontrib>Guo, Xiaoti</creatorcontrib><creatorcontrib>Boyington, Jeffrey C.</creatorcontrib><creatorcontrib>Wei, Chih-Jen</creatorcontrib><creatorcontrib>Nabel, Gary J.</creatorcontrib><creatorcontrib>Argonne National Lab. (ANL), Argonne, IL (United States). Advanced Photon Source (APS)</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale In Context: Middle School</collection><collection>ProQuest Central (Corporate)</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Nursing & Allied Health Database</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Environment Abstracts</collection><collection>Immunology Abstracts</collection><collection>Meteorological & Geoastrophysical Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Agricultural Science Collection</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>Materials Science & Engineering Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>Advanced Technologies & Aerospace Collection</collection><collection>Agricultural & Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>eLibrary</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>Earth, Atmospheric & Aquatic Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Materials Science Collection</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Materials Science Database</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Meteorological & Geoastrophysical Abstracts - Academic</collection><collection>ProQuest Engineering Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Agricultural Science Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest Psychology</collection><collection>Research Library</collection><collection>Science Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Engineering Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>Advanced Technologies & Aerospace Database</collection><collection>ProQuest Advanced Technologies & Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Environmental Science Database</collection><collection>Earth, Atmospheric & Aquatic Science Database</collection><collection>Materials Science Collection</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest One Psychology</collection><collection>Engineering Collection</collection><collection>Environmental Science Collection</collection><collection>ProQuest Central Basic</collection><collection>University of Michigan</collection><collection>Genetics Abstracts</collection><collection>SIRS Editorial</collection><collection>Environment Abstracts</collection><collection>MEDLINE - Academic</collection><collection>OSTI.GOV</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Nature</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lingwood, Daniel</au><au>McTamney, Patrick M.</au><au>Yassine, Hadi M.</au><au>Whittle, James R. R.</au><au>Guo, Xiaoti</au><au>Boyington, Jeffrey C.</au><au>Wei, Chih-Jen</au><au>Nabel, Gary J.</au><aucorp>Argonne National Lab. (ANL), Argonne, IL (United States). Advanced Photon Source (APS)</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Structural and genetic basis for development of broadly neutralizing influenza antibodies</atitle><jtitle>Nature</jtitle><stitle>Nature</stitle><addtitle>Nature</addtitle><date>2012-09-27</date><risdate>2012</risdate><volume>489</volume><issue>7417</issue><spage>566</spage><epage>570</epage><pages>566-570</pages><issn>0028-0836</issn><eissn>1476-4687</eissn><coden>NATUAS</coden><abstract>The events leading to the generation of broadly neutralizing antibodies to influenza viruses, which may hold the key to developing a universal flu vaccine, are elucidated.
Vaccine-friendly anti-influenza antibodies
The study of broadly neutralizing antibodies to influenza virus may pave the way for the generation of a universal vaccine. Here, Daniel Lingwood
et al
. define the minimal requirements for high-affinity binding of such broadly neutralizing antibodies. They show that binding does not involve light chains, and that most of the crucial heavy-chain contacts are germline encoded. Membrane-bound antibodies are shown to function despite their initially very low affinity.
Influenza viruses take a yearly toll on human life despite efforts to contain them with seasonal vaccines. These viruses evade human immunity through the evolution of variants that resist neutralization. The identification of antibodies that recognize invariant structures on the influenza haemagglutinin (HA) protein have invigorated efforts to develop universal influenza vaccines. Specifically, antibodies to the highly conserved stem region of HA neutralize diverse viral subtypes. These antibodies largely derive from a specific antibody gene, heavy-chain variable region
IGHV1-69
, after limited affinity maturation from their germline ancestors
1
,
2
, but how HA stimulates naive B cells to mature and induce protective immunity is unknown. To address this question, we analysed the structural and genetic basis for their engagement and maturation into broadly neutralizing antibodies. Here we show that the germline-encoded precursors of these antibodies act as functional B-cell antigen receptors (BCRs) that initiate subsequent affinity maturation. Neither the germline precursor of a prototypic antibody, CR6261 (ref.
3
), nor those of two other natural human IGHV1-69 antibodies, bound HA as soluble immunoglobulin-G (IgG). However, all three IGHV1-69 precursors engaged HA when the antibody was expressed as cell surface IgM. HA triggered BCR-associated tyrosine kinase signalling by germline transmembrane IgM. Recognition and virus neutralization was dependent solely on the heavy chain, and affinity maturation of CR6261 required only seven amino acids in the complementarity-determining region (CDR) H1 and framework region 3 (FR3) to restore full activity. These findings provide insight into the initial events that lead to the generation of broadly neutralizing antibodies to influenza, informing the rational design of vaccines to elicit such antibodies and providing a model relevant to other infectious diseases, including human immunodeficiency virus/AIDS. The data further suggest that selected immunoglobulin genes recognize specific protein structural ‘patterns’ that provide a substrate for further affinity maturation.</abstract><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>22932267</pmid><doi>10.1038/nature11371</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0028-0836 |
ispartof | Nature, 2012-09, Vol.489 (7417), p.566-570 |
issn | 0028-0836 1476-4687 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7095019 |
source | MEDLINE; Springer Nature - Complete Springer Journals; Nature Journals Online |
subjects | 631/208/248 631/250/2152/2153/1291 631/326/596/1578 Amino Acid Sequence Amino acids Antibodies Antibodies, Neutralizing - chemistry Antibodies, Neutralizing - genetics Antibodies, Neutralizing - immunology Antibodies, Viral - chemistry Antibodies, Viral - genetics Antibodies, Viral - immunology Antibody Affinity - immunology Binding Sites, Antibody - immunology Biological and medical sciences Complementarity Determining Regions - chemistry Complementarity Determining Regions - immunology Cross Reactions - immunology Fundamental and applied biological sciences. Psychology Genetic aspects Health aspects Humanities and Social Sciences Humans Immunoglobulin G - chemistry Immunoglobulin G - immunology Immunoglobulin Heavy Chains - chemistry Immunoglobulin Heavy Chains - immunology Immunoglobulin M - chemistry Immunoglobulin M - immunology Infectious diseases Influenza Influenza vaccines Influenza Vaccines - immunology letter Light Microbiology Models, Molecular Molecular Sequence Data multidisciplinary Mutation Neutralization Orthomyxoviridae - chemistry Orthomyxoviridae - classification Orthomyxoviridae - immunology Prevention Protein Conformation Proteins Receptors, Antigen, B-Cell - chemistry Receptors, Antigen, B-Cell - immunology Science Science (multidisciplinary) Sequence Alignment Testing Vaccines Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies Viral antibodies Virology |
title | Structural and genetic basis for development of broadly neutralizing influenza antibodies |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-21T07%3A30%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Structural%20and%20genetic%20basis%20for%20development%20of%20broadly%20neutralizing%20influenza%20antibodies&rft.jtitle=Nature&rft.au=Lingwood,%20Daniel&rft.aucorp=Argonne%20National%20Lab.%20(ANL),%20Argonne,%20IL%20(United%20States).%20Advanced%20Photon%20Source%20(APS)&rft.date=2012-09-27&rft.volume=489&rft.issue=7417&rft.spage=566&rft.epage=570&rft.pages=566-570&rft.issn=0028-0836&rft.eissn=1476-4687&rft.coden=NATUAS&rft_id=info:doi/10.1038/nature11371&rft_dat=%3Cgale_pubme%3EA660273178%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1095112878&rft_id=info:pmid/22932267&rft_galeid=A660273178&rfr_iscdi=true |